FDA 483 - Eric D. Whitman, MD - December 03, 2020

An FDA inspection of Eric D. Whitman, MD, a clinical investigator in Morristown, NJ, revealed a significant issue regarding the conduct of an investigation. The clinical investigator failed to personally conduct or supervise the study, as unauthorized personnel entered data into electronic case report forms for multiple subjects. This indicates a lack of adherence to the signed statement of investigator.